跳至主要内容
临床试验/KCT0007584
KCT0007584已完成未知

Clinical trial to evaluate efficacy and safety of low molecular collagen peptides for joint pain

Yonsei University Health System, Severance Hospital0 个研究点目标入组 78 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
40(Year) 至 75(Year)(—)
性别
All

入选标准

  • (1) Adult men and women aged 40 years or older and less than 75 years old for more than 6 months after being diagnosed with knee arthritis
  • (2) Those whose Kellgren-Lawrence grading scale of one or both knee joints is grade I or II in simple radiographic examination
  • (3) Those who have knee arthritis pain score of 30 mm or more evaluated by the Visual analog scale (VAS-100 mm)
  • (4) Those with a body mass index (BMI) of less than 30 kg/m2

排除标准

  • (1) Those who have been diagnosed with inflammatory arthritis such as rheumatoid arthritis or lupus arthritis, or have been diagnosed with secondary osteoarthritis due to systemic disease, etc.
  • (2) Those with gout, recurrent pseudogout
  • (3) Those who have infection or severe inflammation of the knee joint, such as septic arthritis
  • (4) If there is a lower extremity fracture within the last 3 months
  • (5) Persons with a history of clinically significant hypersensitivity to collagen components
  • (6) Those who cannot stop taking drugs or health functional foods that affect knee joint pain during the test period from 2 weeks before the first intake of food for human application testing

研究者

相似试验